Related Experiment Videos
Successful long-term immunotherapy for human seminal plasma anaphylaxis
JAMA
|May 25, 1984
Summary
A woman developed anaphylaxis to seminal fluid post-hysterectomy. Successful desensitization immunotherapy using a specific seminal fluid fraction allowed for symptom-free intercourse, requiring ongoing sexual activity to maintain tolerance.
Area of Science:
- Reproductive Immunology
- Allergy and Immunology
Background:
- Seminal plasma hypersensitivity is a rare condition.
- Hysterectomy can potentially alter immune responses.
Observation:
- A 46-year-old woman presented with anaphylactic reactions to her husband's seminal fluid six weeks after a hysterectomy.
- Skin tests and laboratory assays identified a specific fraction of seminal plasma responsible for the allergic reaction.
Findings:
- The patient showed positive skin tests to unfractionated seminal plasma and a specific Sephadex G100 fraction (Fraction 3).
- Fraction 3 induced histamine release from leukocytes and was passively transferable, indicating its allergenic potential.
- A desensitization protocol using Fraction 3 successfully rendered the patient tolerant to seminal fluid exposure.
Implications:
- This case demonstrates the successful application of targeted immunotherapy for seminal plasma hypersensitivity.
- Maintaining tolerance may require regular sexual activity, highlighting the dynamic nature of immune responses.